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all rectum applicators. Simulations in patients 3DCT scan 
allowed us to evaluate CXRT dose to organs at risk and to the 
target volume. The comparison of dosimetric indices of EBRT 
and CXRT treatment delivery for the high risk target volume 
showed that the CXRT technique delivers higher dose to the 
target volume for the same dose, or even less for some cases, 
to the organs at risk. 
 
Conclusion: Monte-Carlo simulations are useful to compute 
accurate dose distributions in 3DCT patient data for the CXRT 
treatment delivery. Moreover, this comparative study 
between the EBRT and CXRT techniques confirms the role of 
CXRT in curative treatment with organ preservation for early 
rectal cancers. 
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Purpose or Objective: In previous studies the dosimetric 
impact of an implanted rectum spacer (IRS) in prostate 
cancer patients undergoing intensity-modulated radiation 
therapy (IMRT) has been assessed by dose-volume histograms 
(DVHs) and dose-surface histograms (DSHs) obtained from 3D 
dose distributions of the ano-rectal wall (ARW). 
Unfortunately, spatial information is lost when analyzing 
DVHs or DSHs. This hampers to study the correlation between 
the shape and location of the ARW dose distribution and 
clinical outcome. Dose-surface maps (DSMs) have been 
suggested as a valuable tool for taking the spatial-dosimetric 
information into account.The purpose of this study is to 
assess spatio-dosimetric differences in DSMs obtained from 
planned ARW dose distributions in patients receiving IMRT 
with and without IRS (IMRT+IRS; IMRT-IRS, respectively). 
 
Material and Methods: In 26 patients with localized prostate 
cancer a hydrogel rectum spacer (SpaceOAR®, Augmenix) was 
injected under transrectal ultrasound guidance in 
Denonvilliers’ space between the prostate and the rectal 
wall. Per patient, two IMRT treatment plans (78 Gy in 39 
fractions) were designed, based on CT scans acquired before 
and after hydrogel injection. DSMs of the ARW were 
generated from the planned 3D dose distributions by virtual 
unfolding the rectum contour as described in Buettner et al. 
(Fig. 1a-b).  
 
 
Various shape-based dose measures were extracted from the 
DSMs. First, dose clusters were generated by thresholding the 
DSMs at 38 dose levels ranging from 5-79 Gy. Then, for each 
dose level an ellipse was fitted to the largest dose cluster. 
Lateral (posterior-anterior-posterior) and longitudinal 
(superior-inferior) extents were quantified by projecting the 
major and minor axes of this ellipse to the main axes of the 
DSMs. The non-circularity of the dose clusters was described 
by the eccentricity of the ellipse. The contiguity of the ARW 
dose distribution was assessed by the contiguous-DSH (cDSH), 
reflecting the single largest contiguous ARW area fraction as 
function of the dose threshold at the given level. Statistical 
differences were assessed with a one-sided paired Wilcoxon 
signed rank test. 
 
Results: Lateral extent, longitudinal extent as well as cDSH 
were significantly lower in IMRT+IRS than for IMRT-IRS at 
high-dose levels. Largest significant differences were 
observed for cDSH at dose levels >50Gy, followed by lateral 
extent at doses >57Gy, and longitudinal extent. For these 
three features, no significant differences were observed for 
low to medium dose levels. For eccentricity no significant 
differences were found, independent of the dose level. 
 
Conclusion: Significant spatio-dosimetric differences in ARW 
DSMs exist between prostate cancer patients undergoing IMRT 
with and without IRS. The IRS particularly reduces the lateral 
and longitudinal extent of high-dose areas (>50 Gy) in 
anterior and superior-inferior directions. 
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Purpose or Objective: SBRT is a novel treatment procedure, 
which is used for the particular localization of the tumor to 
deliver targeted high doses with greatly precise fields. 
Different irradiation techniques provide a wide spectrum of 
therapy options. The aim of this work was to evaluate the 
clinical benefits and potential dosimetric of different 
planning methods against each other for the treatment of 
NSCLC. 
 
Material and Methods: In this study, three diagnosed 
patients with NSCLC metastasis, were chosen. One had a 
peripheral metastasis in the left lung , the other had a 
metastasis in the right lung, and the last one had a central 
metastasis located near to vertebral body. The delineated 
structures (PTV and OARs) on CT were shared among 22 
clinics with the request to generate an irradiation plan with 
their own internal criteria. Three fractions of 15 Gy were 
prescribed to the PTV-enclosing 65%. All together it was 
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assembled 78 treatment plans, that they were generated, 36 
IMAT, 18 3DCRT, 3 IMRT, 9 helical irradiation and 12 robotic 
radiosurgery. All gathered data were finally imported into 
one treatment planning system for evaluating different 
planning strategies. 
 
Results: In all plans, the dosimetric coverage of the target 
volume and the dose to OARs were within clinical limits. The 
coverage of the PTV were disclosed: CICRU =1.0(0.9-1.1); 
CI65 =0.7(0.4-1.0); HI=0.3(-0.3-0.5); Dmin/Dmax=0.6(0.5-
0.7); D2%,=64.6(47.5-71.3)Gy; D98%=47.2(39.5-68.6)Gy; 
Dmiddle=57.8(47.3-65.8)Gy. 
In the 3DCRT Plans, the mean dose in the PTV was on 
average, 3 Gy higher than dynamic techniques; MU and 
irradiation time were by the factor of 2-3 higher in the 
dynamic techniques. Dose to the OARs for the 1st and 2nd 
patient is as bellows: Dmedi, ipsilat. lung = 4.9 (3.2-8.8)Gy; 
Dmax, esophagus =7.7(0.4-16.1)Gy. V35Gy, rips =10(0.6-
43.7). For the 3rd one: Dmedi., ipsilat. lung = 8.3(6.8-10)Gy; 
Dmedi.,contralat. lung = 2.3(1.4-4.7)Gy Dmax, 
esophagus=20.7(11.3-27.7)Gy. 




Conclusion: All irradiation techniques were applicable for 
clinical use, the resulting dose distribution were quite 
similar. By comparison, the statistically significant 
differences between the users were greater than the 
differences between the techniques. This demonstrate that 
strict constrains and works like the DEGRO reference paper 
(Guckenberger et al) are necessary to homogenize the SBRT 
planning at a national level. 
This study reports the results of the irradiation planning for 




Developing sciatic nerve-sparing stereotactic radiotherapy 
for re-irradiating the pelvic sidewall 
M. Llewelyn
1Royal Marsden NHS Foundation Trust, Department of 
Gynaecology, London, United Kingdom 
1, E. Wells2, A. Taylor1 
2Royal Marsden NHS Foundation Trust, Department of 
Radiotherapy, London, United Kingdom 
 
Purpose or Objective: Management of pelvic sidewall 
recurrence in gynaecological cancers is a challenging clinical 
scenario. Sciatic nerve involvement may exclude surgery and 
cause intractable symptoms that are difficult to palliate. In 
the context of re-irradiation, high doses of radiation without 
consideration of the sciatic nerve can cause irreversible 
nerve damage, yet this has not traditionally been included as 
an OAR.  
The aims of this study were to develop dose target 
constraints for re-irradiation of the sciatic nerve, and to 
assess the impact of nerve-sparing optimisation on target 
volume coverage and OAR sparing with stereotactic 
radiotherapy techniques. 
 
Material and Methods: Cumulative dose constraints for re-
irradiation were derived assuming prior pelvic radiotherapy 
of 50Gy (EQD2) and allowing nerve recovery values of 50% 
and 100%. Treatment plans were produced for 10 patients 
with recurrent gynaecological cancer delivering 30 Gy in 5 
fractions. Two normalisation methods were assessed: ICRU 83 
type normalisation and prescription (ICRU); and stereotactic 
radiosurgery convention of prescribing to the isodose 
covering 95% PTV allowing maximum doses of ~125% (SRS). 
For each method, plans were optimised with and without 
sciatic nerve sparing targets. Sciatic nerve roots were 
contoured from sacral foramina until the nerve exits the 
pelvis. Nerve sparing plans were optimised to minimize dose 
to nerve PRV while maintaining PTV coverage. Doses to GTV, 
PTV, OAR and sciatic nerve were compared. 
 
Results: All 40 plans met the PTV targets with >95% PTV 
coverage by the specified isodose. The sciatic nerve was 
involved in 3 patients, close proximity (<5 mm) in 4 patients 
and more than 5 mm distant from PTV in 3 patients. The dose 
targets were Dmax 32 Gy when there was nerve involvement 
and 21.9 Gy when the nerve was distant from tumour. For all 
patients, the sciatic nerve dose was reduced with each 
technique: median Dmax with ICRU from 28.8 Gy to 22.3 GY 
and with SRS from 28.7 Gy to 19.9 Gy. For patients with overt 
nerve involvement, median Dmax was reduced from 34.9 Gy 
to 32.1 Gy with SRS. Nerve sparing was achieved without 
significantly decreasing GTV mean doses or increasing bowel 
doses.  
 
Conclusion: The sciatic nerve should be an OAR for re-
irradiation of sidewall recurrence. Optimisation using a 
sciatic nerve PRV can significantly reduce dose to nerve by up 
40% (EQD2-2) while having minimal effect on GTV coverage or 
bowel doses. Feasible dose targets depend on proximity of 
nerve to GTV and clinical scenario.  
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Purpose or Objective: Over the last half century we have 
seen remarkable improvements in the survival of pediatric 
cancer patients. Therefore, the impact of cancer and its 
treatment must be assessed. Furthermore, the radiotherapy 
technique must be well selected in order to minimize the 
secondary effects. Since hearing loss is a common late effect 
of radiotherapy, the purpose of this study was to compare 
three different treatment techniques and to evaluate the 
dose to the cochleas and supretentorial brain, in children 
treated with radiotherapy for medulloblastoma.  
 
Material and Methods: A total of 121 children were treated 
in our department with radiotherapy for CNS tumors, 
between January 2000 and December 2014. Those who were 
diagnosed with medulloblastoma were included. A total of 29 
children fulfilled these criteria. The adopted treatment plan 
consisted of a first phase with three-dimensional conformal 
radiotherapy (3D-CRT) to the craniospinal region (prescribed 
doses from 23.4 to 36.0 Gy) followed with a boost to the PTV 
(posterior fossa/tumor bed) with prescribed doses of 18.0 or 
31.6 Gy depending on the clinical risk-group, high or standard 
risk respectively . For each child, three different treatment 
plans were prepared for the boost phase: one with 
conventional 2 parallel opposed fields (CRT), one more 
complex with 3D conformal radiotherapy (3D-CRT) and 
